Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation
Mojdeh Amini Faskhoudi, Pejman Molaei, Mehrdokht Sadrkhanloo, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153851-153851
Closed Access | Times Cited: 25

Showing 25 citing articles:

Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Ischemia-reperfusion injury in human AC16 cardiomyocytes is modulated by AXIN1 depending on c-Myc regulation
Jun Li, Hao Wang, Li Chen, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 10, pp. 4844-4850
Open Access | Times Cited: 19
Discovery of a Potent and Selective GSPT1 Molecular Glue Degrader for the Treatment of Castration-Resistant Prostate Cancer
Hui Shen, Hongrui Xu, W. Q. Jin, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Key Considerations for a Prostate Cancer mRNA Vaccine
Guofu Lin, Ahmed Elkashif, Chayanika Saha, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104643-104643
Open Access
Contemporary review of prognostic markers of prostate cancer from a pathologist perspective
Martin Eliáš, Jan Bouchal, Milan Král, et al.
Biomedical Papers (2025)
Open Access
MED12 and CDK8/19 modulate androgen receptor activity and enzalutamide response in prostate cancer
Chiara Andolfi, Caterina Bartolini, Elisa Morales, et al.
Endocrinology (2024) Vol. 165, Iss. 10
Open Access | Times Cited: 4
Deregulated transcription factors in the emerging cancer hallmarks
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin, et al.
Seminars in Cancer Biology (2023) Vol. 98, pp. 31-50
Closed Access | Times Cited: 10
MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer
Alireza Azani, Sima Parvizi Omran, Haniyeh Ghasrsaz, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154618-154618
Closed Access | Times Cited: 9
Development, synthesis and validation of improved c‐Myc/Max inhibitors
Sümbül Yıldırım, Fatih Kocabaş, Arif Mermer
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 2
Vascular mimicry: A potential therapeutic target in breast cancer
Hadi Chavoshi, Neda Poormolaie, Vahid Vahedian, et al.
Pathology - Research and Practice (2022) Vol. 234, pp. 153922-153922
Closed Access | Times Cited: 14
Cardiovascular/Stroke Risk Assessment in Patients with Erectile Dysfunction—A Role of Carotid Wall Arterial Imaging and Plaque Tissue Characterization Using Artificial Intelligence Paradigm: A Narrative Review
Narendra N. Khanna, Mahesh Maindarkar, Ajit Kumar Saxena, et al.
Diagnostics (2022) Vol. 12, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 14
STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
Sandra M. Rocha, Daniel Nascimento, Rafaella S. Coelho, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6643-6643
Open Access | Times Cited: 5
Aptamer guided nanomedicine strategies in prostate cancer: Targeting and diagnosis
Syed Shahrukh, Naitik Jain, Saurabh Shah, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 85, pp. 104593-104593
Closed Access | Times Cited: 5
The Oncogenic Protein Kinase/ATPase RIOK1 Is Up-Regulated via the c-myc/E2F Transcription Factor Axis in Prostate Cancer
Florian Handle, Martin Puhr, Martina Gruber, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 9, pp. 1284-1297
Open Access | Times Cited: 5
Androgen Receptor–Interacting Proteins in Prostate Cancer Development and Therapy Resistance
Zoran Čulig, Martin Puhr
American Journal Of Pathology (2023) Vol. 194, Iss. 3, pp. 324-334
Open Access | Times Cited: 5
Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4
Yasamin Azimi, Sara Hajibabaei, Ghazal Azimi, et al.
Genes & Cancer (2024) Vol. 15, pp. 28-40
Open Access | Times Cited: 1
The evaluation of melatonin and EGF interaction on breast cancer metastasis
Moloud Akbarzadeh, Vahid Vahedian, Zahraa Hamid Abudulmohesen, et al.
Hormone Molecular Biology and Clinical Investigation (2024) Vol. 45, Iss. 3, pp. 119-130
Closed Access | Times Cited: 1
Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view
Fatemeh Ebadi Meinag, Mina Fatahi, Vahid Vahedian, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 1
STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide
Sandra M. Rocha, Daniel Nascimento, Ana Cardoso, et al.
Molecular Medicine Reports (2023) Vol. 27, Iss. 2
Open Access | Times Cited: 2
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression
Anna Besschetnova, Wanting Han, Mingyu Liu, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 8, pp. 1716-1730
Open Access | Times Cited: 2
Daurisoline inhibits glycolysis of lung cancer by targeting the AKT-HK2 axis
Shiming Tan, Lan Luo, Yi-Fu He, et al.
Cancer Biology & Therapy (2024) Vol. 26, Iss. 1
Open Access
Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers
Chenchen He, Wang Liu, Jiahao Sun, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6)
Fahimeh Tabakhiyan, Amirabbas Mir, Vahid Vahedian
Hormone Molecular Biology and Clinical Investigation (2022) Vol. 43, Iss. 4, pp. 389-396
Closed Access | Times Cited: 2
Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea
Nadereh Bakhshandeh, Maryam Mohammadi, Parisa Mohammadi, et al.
Hormone Molecular Biology and Clinical Investigation (2022) Vol. 44, Iss. 2, pp. 181-186
Closed Access | Times Cited: 2
Association of S19W polymorphism in APOA5 gene and serum lipid levels in patients with type 2 diabetic nephropathy
Shivasadat Mirabedini, Hadis Musavi, Atieh Makhlough, et al.
Hormone Molecular Biology and Clinical Investigation (2023) Vol. 44, Iss. 3, pp. 243-249
Closed Access
Page 1

Scroll to top